TalibegronAlternative Names: ICI D 2079; SCH 417849; ZD 2079
Latest Information Update: 07 Feb 2003
At a glance
- Originator AstraZeneca
- Class Small molecules
- Mechanism of Action Beta 3 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus